{
    "1628473332512313346": {
        "author_id": "194037150",
        "created_at": "2023-02-22T19:14:32.000Z",
        "edit_history_tweet_ids": [
            "1628473332512313346"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 82,
                    "normalized_text": "China",
                    "probability": 0.9728,
                    "start": 78,
                    "type": "Place"
                },
                {
                    "end": 164,
                    "normalized_text": "Benedikte",
                    "probability": 0.477,
                    "start": 156,
                    "type": "Other"
                },
                {
                    "end": 180,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.5042,
                    "start": 169,
                    "type": "Organization"
                }
            ],
            "mentions": [
                {
                    "end": 8,
                    "id": "1271637850660847616",
                    "start": 0,
                    "username": "Don5188"
                },
                {
                    "end": 39,
                    "id": "737983923335090176",
                    "start": 23,
                    "username": "novonordiskfond"
                }
            ]
        },
        "id": "1628473332512313346",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 229,
            "like_count": 0,
            "quote_count": 0,
            "reply_count": 0,
            "retweet_count": 0
        },
        "text": "@Don5188 @Emmawang2018 @novonordiskfond Hi; I have reached out to our team in China and will get once I hear from them. Sorry about this inconvenience\nBest\nBenedikte // Novo Nordisk"
    }
}